[天津癌症存活率分析,2010年至2016年]
1Department of Cancer Registration, Institution of Noncommunicable Disease Prevention and Control, Tianjin Center for Disease Control and Prevention, Tianjin 300011, China.
Zhonghua zhong liu za zhi [Chinese journal of oncology]
|April 21, 2024
概括
天津的癌症存活率从2010年至2016年显著增加,显示出预防和治疗效率的提高. 重点仍然是男性,农村人口,老年人,以及特定的癌症,如肺癌和肝癌.
科学领域:
- 在瘤学瘤学.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 2010年至2016年间,来自中国天津的癌症发病率和存活率数据.
- 分析旨在为预防和治疗癌症的区域卫生政策提供信息.
研究的目的:
- 为了对天津的癌症发病率进行生存分析.
- 评估区域卫生政策的有效性.
主要方法:
- 使用生命表和Ederer II方法来计算生存率.
- 采用卡普兰-梅尔和Log等级测试进行生存曲线比较.
- 应用联合点回归来分析癌症存活率的趋势变化.
主要成果:
- 天津的癌症5年相对存活率从41.92%增加到53.65% (2010-2016),平均为48.56%.
- 女性 (57.71%) 和城市居民 (49.38%) 的生存率高于男性 (39.20%) 和农村居民 (47.24%).
- 平均存活时间也呈现出日益增长的趋势,平均为4.11年,人口统计和年龄组之间存在显著差异.
结论:
- 天津的癌症存活率在2010年至2016年期间显著改善,这表明了有效的癌症控制措施.
- 未来的努力应该针对男性,农村人口和老年人.
- 建议特别关注肺癌,食道癌,肝癌,胆囊癌和胰腺癌.
相关概念视频
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345
Comparing the Survival Analysis of Two or More Groups
179
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
179
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Introduction To Survival Analysis
228
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
The primary goal of survival analysis is to estimate survival time—the time...
228
Actuarial Approach
77
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
77
Tumor Immunotherapy
522
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
522


